The Antisera market in Colombia experienced fluctuations between 2013 and 2023, starting at $2.444 billion in 2013 and slightly declining to $2.099 billion in 2023, indicated by various year-on-year shifts. Over the last five years, the market faced a negative compound annual growth rate (CAGR) of -0.16%. Despite some years of growth, such as 2021's 4.84% uptick, the market generally displays a minor downward trend.
Looking ahead, the following future trends are crucial for the Antisera market:
- Technological advancements in biotechnology, potentially driving breakthroughs.
- Changes in healthcare policies affecting import and use.
- The emergence of new players and competitive dynamics within the Latin American region.
- Fluctuations in demand due to socio-economic and epidemiological factors.
